Laura F Hutchins Selected Research

Pathologic Complete Response

1/2017	Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.
1/2016	High-circulating Tie2 Is Associated With Pathologic Complete Response to Chemotherapy and Antiangiogenic Therapy in Breast Cancer.
2/2015	Combined neoadjuvant chemotherapy with bevacizumab improves pathologic complete response in patients with hormone receptor negative operable or locally advanced breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura F Hutchins Research Topics

Disease

24	Breast Neoplasms (Breast Cancer) 01/2023 - 11/2002
15	Neoplasms (Cancer) 01/2023 - 03/2003
11	Melanoma (Melanoma, Malignant) 01/2021 - 04/2007
3	Pathologic Complete Response 01/2017 - 02/2015
2	Ductal Carcinoma 01/2016 - 02/2015
2	Neoplasm Metastasis (Metastasis) 01/2016 - 04/2014
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2015 - 06/2005
2	Sarcoma (Soft Tissue Sarcoma) 06/2015 - 02/2002
1	Exanthema (Rash) 01/2021
1	Colitis 01/2016
1	Pancreatitis 01/2016
1	Diarrhea 01/2016
1	Uterine Cervical Dysplasia 10/2015
1	Thrombotic Thrombocytopenic Purpura 02/2015
1	Merkel Cell Carcinoma 01/2014
1	Neutropenia 11/2010
1	Disorders of Excessive Somnolence (Hypersomnia) 07/2010
1	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2010
1	Brain Neoplasms (Brain Tumor) 01/2010
1	Bone Diseases (Bone Disease) 07/2008
1	Osteoporosis 07/2008
1	Vitamin D Deficiency 07/2008

Drug/Important Bio-Agent (IBA)

7	Hormones (Hormone)IBA 01/2023 - 01/2005
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 01/2005
5	Tamoxifen FDA LinkGeneric 04/2008 - 11/2002
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2005
3	IpilimumabIBA 01/2021 - 01/2016
3	CarbohydratesIBA 01/2020 - 04/2007
3	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 01/2005
3	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 01/2005
3	Bevacizumab (Avastin)FDA Link 01/2017 - 02/2015
2	InterferonsIBA 01/2021 - 11/2007
2	VaccinesIBA 01/2020 - 10/2015
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	AntigensIBA 01/2020 - 04/2007
2	Peptides (Polypeptides)IBA 01/2020 - 10/2015
2	AntibodiesIBA 11/2017 - 04/2007
2	Protein Subunit VaccinesIBA 11/2017 - 04/2007
2	Monoclonal AntibodiesIBA 01/2016 - 01/2016
2	EnzymesIBA 11/2010 - 03/2003
2	Thalidomide (Thalomid)FDA Link 01/2010 - 11/2007
2	AnthracyclinesIBA 03/2008 - 02/2007
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	peptide AIBA 01/2020
1	Interferon alpha-2 (Roferon-A)FDA Link 01/2020
1	Melanins (Melanin)IBA 12/2019
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 11/2017
1	CTLA-4 AntigenIBA 07/2017
1	Antigen-Antibody Complex (Immune Complex)IBA 07/2017
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2016
1	Blood Glucose (Blood Sugar)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Histones (Histone)IBA 01/2016
1	Histone MethyltransferasesIBA 01/2016
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2016
1	Polycomb Repressive Complex 2IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 10/2015
1	Vaccine AdjuvantsIBA 10/2015
1	pazopanib FDA Link 06/2015
1	thiamine triphosphorate (TTP)IBA 02/2015
1	Rituximab (Mabthera)FDA Link 02/2015
1	ADAMTS13 ProteinIBA 02/2015
1	Factor VIII (Coagulation Factor VIII)IBA 02/2015
1	Estrogen ReceptorsIBA 02/2015
1	von Willebrand FactorIBA 02/2015
1	VemurafenibIBA 04/2014
1	Genetic Markers (Genetic Marker)IBA 12/2010
1	AntioxidantsIBA 11/2010
1	Superoxide DismutaseIBA 11/2010
1	Temozolomide (Temodar)FDA LinkGeneric 01/2010
1	Dacarbazine (DIC)FDA LinkGeneric 01/2010
1	NRH - quinone oxidoreductase2IBA 08/2009
1	Nitric Oxide Synthase (NO Synthase)IBA 08/2009
1	Vitamin D FDA LinkGeneric 07/2008
1	Diphosphonates (Bisphosphonates)IBA 07/2008
1	CalciumIBA 07/2008
1	exemestane (Aromasin)FDA Link 04/2008
1	Dihydrotachysterol (AT 10)IBA 03/2008
1	Cytidine Monophosphate (CMP)IBA 04/2007
1	Immunoglobulin M (IgM)IBA 04/2007
1	Cytostatic AgentsIBA 01/2005
1	Glutathione Transferase (Glutathione S-Transferase)IBA 03/2003

Therapy/Procedure

11	Therapeutics 01/2020 - 11/2002
7	Drug Therapy (Chemotherapy) 01/2020 - 02/2007
3	Radiotherapy 01/2023 - 01/2005
3	Adjuvant Chemotherapy 01/2019 - 03/2008
3	Neoadjuvant Therapy 01/2017 - 04/2011
3	Aftercare (After-Treatment) 12/2014 - 03/2003
2	Segmental Mastectomy (Lumpectomy) 01/2023 - 01/2005
1	Lasers (Laser) 12/2019
1	Terminal Care (Care, Terminal) 07/2018
1	Immunotherapy 07/2017
1	Plasma Exchange 02/2015
1	Radical Mastectomy 04/2011
1	Treatment Delay 05/2009
1	Secondary Prevention 05/2009
1	Nephrectomy 06/2005
1	Combination Drug Therapy (Combination Chemotherapy) 03/2003